19534693

Source:http://linkedlifedata.com/resource/pubmed/id/19534693

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0035168, umls-concept:C0255161, umls-concept:C0332185, umls-concept:C1413666, umls-concept:C1527148
pubmed:issue	10
pubmed:dateCreated	2009-10-12
pubmed:abstractText	Thrombin-activatable fibrinolysis inhibitor (TAFI) provides an important molecular link between the coagulation and fibrinolytic systems. In this review, recent major advances in TAFI research, including the elucidation of crystal structures, the development of small inhibitors and the role of TAFI in systems other than hemostasis, are described and discussed.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101094212
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carboxypeptidase U
pubmed:status	MEDLINE
pubmed:month	Sep
pubmed:issn	1389-5575
pubmed:author	pubmed-author:MarxPauline FPF, pubmed-author:MeijersJoost C MJC, pubmed-author:Valls SeronMercedesM, pubmed-author:VerkleijChantal J NCJ
pubmed:issnType	Print
pubmed:volume	9
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1165-73
pubmed:dateRevised	2010-8-30
pubmed:meshHeading	pubmed-meshheading:19534693-Animals, pubmed-meshheading:19534693-Carboxypeptidase U, pubmed-meshheading:19534693-Gene Expression, pubmed-meshheading:19534693-Humans, pubmed-meshheading:19534693-Models, Molecular
pubmed:year	2009
pubmed:articleTitle	Recent developments in thrombin-activatable fibrinolysis inhibitor research.
pubmed:affiliation	Department of Experimental Vascular Medicine, G1-145, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. p.f.marx@amc.uva.nl
pubmed:publicationType	Journal Article, Review, Research Support, Non-U.S. Gov't